Peter Kennealey, MD
Transplant Surgery · Aurora, CONPI 1073718680
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 82.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $18,311 and has fallen 98.7% since, to $247 in 2025. Among transplant surgery clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $747.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$25K
- Artegraft Inc.$5K
- Johnson & Johnson$148
- W. L. Gore & Associates, Inc.$131
- Medtronic$112
- Lemaitre Vascular, Inc.$98
What the payments were for
- Consulting fees$18,27560%
- Speaking & faculty fees$2,0007%
- Travel & lodging$7,40224%
- Food & beverage$2,95310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 30 | $25,139 |
| Artegraft Inc. | 6 | $5,000 |
| Johnson & Johnson | 1 | $148 |
| W. L. Gore & Associates, Inc. | 1 | $131 |
| Medtronic | 1 | $112 |
| Lemaitre Vascular, Inc. | 2 | $98 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$25,139
- SURGICEL NU-KNIT$148
- GORE VIABAHN Endoprosthesis$131
- ENDO GIA ULTRA$112
How this compares
$30,629 in reported general payments places this provider in the 90th percentile of 22 transplant surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $174 |
| Cephalexin | 30 | $58 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Aurora
- Thomas PshakAurora$33K
- Hunter MooreAurora$28K
- Phillipe Geraldo Teixeira de Abreu ReisAurora$7K
- Kendra ConzenAurora$5K
- Rashikh ChoudhuryAurora$4K
- Perveshinder GrewalAurora$3K
- Trevor NydamAurora$2K
- James PomposelliAurora$1K
- Kristin MekeelAurora$1K
- Thomas BakAurora$840
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.